Timothy J. Sangiovanni is VP & Controller at ZEVRA THERAPEUTICS, INC. (ZVRA). They have made 6 open-market trades across 2 companies since 2018, most recently 2026-02-03.
CIK 0001698328
5 open-market purchases totalling $18K since 2018, against 1 sale. Across 5 scored buys the stock is down 9.8% at ninety days, and 20.3 points behind the S&P over the same stretch.
5 scored purchases · one row per filing · discretionary only
| Ticker | Shares | Value |
|---|---|---|
| ZVRA | 29,590 | $294K |
| KMPH | 18,000 | $105K |
| Total | $398K |
Shares reported on the most recent Form 4, priced at the 2026-02-04 close.
Counted per filing, not per execution lot — a purchase filled in several tranches is one decision.
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 40% | 40% | 60% |
| Avg Move | -1.1% | +1.6% | -9.8% |
| Alpha | +1.9% | -1.6% | -20.3% |
| Scored | 5 | 5 | 5 |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| ZVRA | SELL · 10b5-1 | 2026-02-03 | 2026-02-04 | $9.18 | $28K | -3.2% | +1.2% | +19.6% |
| ZVRA | SELL | 2026-01-30 | 2026-02-02 | $8.82 | $15K | -9.3% | -3.6% | +8.5% |
| ZVRA | SELL · 10b5-1 | 2025-02-13 | 2025-02-14 | $7.86 | $24K | -3.0% | +4.0% | +5.0% |
| ZVRA | BUY | 2023-03-10 | 2023-03-13 | $4.14 | $5K | +25.4% | +40.8% | +29.2% |
| KMPH | BUY | 2020-03-13 | 2020-03-16 | $0.20 | $800 | +9.5% | +28.0% | +3.0% |
| KMPH | BUY | 2020-03-09 | 2020-03-10 | $0.26 | $2K | -22.1% | -15.1% | -24.1% |
| KMPH | BUY | 2019-09-24 | 2019-09-25 | $0.74 | $2K | -10.1% | -38.7% | -64.4% |
| KMPH | BUY | 2018-10-11 | 2018-10-15 | $2.53 | $8K | -8.4% | -7.2% | +7.6% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.